15 Apr 2020 - Baby formula brand Bubs Australia (ASX:BUB) have reported a positive operating cashflow of $2.3 million on sales of $23.4 million for the first 2020 quarter ending March 31, 2020.
15 Apr 2020 - Production at Lynas Corporation's (ASX:LYC) Malaysian plant is set to continue it’s temporary halt.
15 Apr 2020 - MLC Senior Economist Bob Cunneen discusses the ongoing impact of the coronavirus on markets including central bank and government measures.
15 Apr 2020 - The ASX looks set to open higher this morning. On Wall Street shares rose on hopes the US is moving closer to at least a partial reopening of its economy during the coronavirus pandemic. The Dow was up 2.5% near the closing bell. The International Monetary Fund is warning Australia's economy could shrink by 6.7 per cent this year. Stockland (ASX:SGP) has put in place additional unsecured bank debt facilities totalling $350 million.
14 Apr 2020 - Genetic Signatures (ASX:GSS) has received notice from the Therapeutic Goods Administration (“TGA”) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.
14 Apr 2020 - Smart building materials company ClearVue Technologies (ASX:CPV) has entered into a Collaboration Agreement with eLstar Dynamics B.V in the Netherlands.
14 Apr 2020 - The ASX had a little dip in early morning trade but then rose within the first hour of trading now tracking almost 0.5% higher at noon. Energy companies have opened mixed following the deal among Opec and other oil producing nations to cut crude production. Gold producers are all up. Bega Cheese (ASX:BGA) wins Kraft Heinz legal proceedings.
14 Apr 2020 - It has been a mostly positive day of trade for the ASX after a small dip in early morning trade the local bourse managed to close 1.9% higher. As for the sectors today Infotech led the day and REITs the only sector to end the day lower. Centuria Industrial REIT (ASX:CIP) has completed a $130 million institutional placement.
14 Apr 2020 - Cyclopharm (ASX:CYC) is pleased to announce that the United States Food and Drug Administration (USFDA) has granted the Company a full application fee waiver of USD $2.9 million related to its recently submitted New Drug Application (NDA) for Technegas.
14 Apr 2020 - InvoCare (AX:IVC) funeral homes is raising $150m through an underwritten institutional Placement to continue momentum achieved on its growth initiatives through the temporary restrictions on the funeral industry as a result of COVID-19.
